The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

I.D. Rozanov

S.P. Botkin City Clinical Hospital

S.S. Lebedev

S.P. Botkin City Clinical Hospital

D.N. Grekov

S.P. Botkin City Clinical Hospital

T.A. Yakusheva

S.P. Botkin City Clinical Hospital

A.S. Balkanov

M.F. Vladimirsky Regional Research Clinical Institute

Drug therapy for brain glioblastoma


I.D. Rozanov, S.S. Lebedev, D.N. Grekov, T.A. Yakusheva, A.S. Balkanov

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2023;12(5): 65‑70

Views: 647

Downloaded: 1

To cite this article:

Rozanov ID, Lebedev SS, Grekov DN, Yakusheva TA, Balkanov AS. Drug therapy for brain glioblastoma. P.A. Herzen Journal of Oncology. 2023;12(5):65‑70. (In Russ.)

Recommended articles:
Use of Atezolizumab in patients with adva­nced small cell lung cancer. P.A. Herzen Journal of Onco­logy. 2023;(6):63-67
Treatment of meta­static pheochromocytoma and para­ganglioma. P.A. Herzen Journal of Onco­logy. 2024;(1):70-75
Asse­ssment of risk factors for progression and recu­rrence of ovarian endo­metriosis. Russian Bulletin of Obstetrician-Gynecologist. 2023;(3):127-132
Preoperative predictors of obesity recu­rrence after lapa­roscopic gastrectomy. Piro­gov Russian Journal of Surgery. 2023;(9):40-44

Email Confirmation

An email was sent to with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.